HealthEquity Inc (HQY)
Return on equity (ROE)
| Jan 31, 2025 | Jan 31, 2024 | Jan 31, 2023 | Jan 31, 2022 | Jan 31, 2021 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 96,703 | 55,712 | -26,143 | -44,289 | 8,834 |
| Total stockholders’ equity | US$ in thousands | 2,114,910 | 2,035,020 | 1,895,640 | 1,852,580 | 1,378,730 |
| ROE | 4.57% | 2.74% | -1.38% | -2.39% | 0.64% |
January 31, 2025 calculation
ROE = Net income ÷ Total stockholders’ equity
= $96,703K ÷ $2,114,910K
= 4.57%
HealthEquity Inc's return on equity (ROE) has shown a fluctuating trend over the past five years. In January 2021, the ROE was quite low at 0.64%, indicating a relatively weak profitability relative to shareholders' equity. By January 2022, the ROE turned negative at -2.39%, signaling a loss on equity investment during that period.
However, there was a slight improvement in January 2023, with the ROE increasing to -1.38%, suggesting a potential recovery in profitability but still below the positive threshold. Subsequently, in January 2024, HealthEquity Inc managed to achieve a positive ROE of 2.74%, demonstrating better profitability relative to shareholders' equity.
The latest data point in January 2025 shows a further improvement in ROE to 4.57%, indicating a more favorable return on the equity investment. Overall, while there have been fluctuations in HealthEquity Inc's ROE over the years, the recent positive trend suggests an enhanced profitability performance and efficiency in utilizing shareholders' equity.
Peer comparison
Jan 31, 2025